Allopurinol - Advancell

Drug Profile

Allopurinol - Advancell

Alternative Names: ATH-008; ATH-008 cream

Latest Information Update: 12 Aug 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Nobera Pharma
  • Developer Advancell
  • Class Antigouts; Purines; Skin disorder therapies
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Erythrodysaesthesia; Unspecified

Most Recent Events

  • 15 Mar 2016 Biomarkers information updated
  • 10 Jul 2013 Preclinical trials in Undefined indication in Spain (unspecified route)
  • 09 Jul 2013 ATH 008 licensed to Helsinn worldwide
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top